Coronavirus / COVID

Latest News

 The group includes Michael Peluso, MD, MHS; Amy Proal, PhD; and David Putrino, PhD, and will study monoclonal antibody therapies targeting persistent spike protein.
Invivyd Forms SPEAR Study Group to Investigate Pemivibart for Long COVID and Post-Vaccination Syndrome

July 8th 2025

Invivyd forms the SPEAR Study Group to evaluate pemivibart for Long COVID and post-vaccine syndrome, exploring monoclonal antibody treatment of spike protein.

Medical Societies Sue HHS and Secretary Kennedy Over COVID-19 Vaccine Policy Changes
Medical Societies Sue HHS and Secretary Kennedy Over COVID-19 Vaccine Policy Changes

July 7th 2025

Monoclonal Antibody Shows 84% Relative Risk Reduction of Symptomatic COVID-19 vs Placebo
Monoclonal Antibody Shows 84% Relative Risk Reduction of Symptomatic COVID-19 vs Placebo

June 29th 2025

ACIP June 2025: COVID-19 Trends, Vaccine Updates, and Targeted Recommendations
ACIP June 2025: COVID-19 Trends, Vaccine Updates, and Targeted Recommendations

June 25th 2025

The Lingering Threat: Managing Severe COVID-19 in the Postpandemic Era
The Lingering Threat: Managing Severe COVID-19 in the Postpandemic Era

June 12th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.